Portfolio
4
companies
Permutive
Permutive builds privacy first infrastructure for programmatic advertising.
Exscientia
Exscientia builds artificial intelligence platforms to design and discover new medicines.
PatSnap
PatSnap provides an innovation intelligence platform for research and development teams.
Greensill
Greensill provides working capital finance to companies globally using technology.
Masayoshi Son
LinkedInColin Fan
managing partner
Eric Chen
Managing Partner of SoftBank Investment Advisers
Max Ohrstrand
investor
The round was led by SoftBank Vision Fund 2 with participation from existing investors to scale on-device technology.
"Publishers are the foundation of the web, and the relationship they have with their users is the backbone of digital advertising,"
The financing was led by SoftBank Vision Fund 2 with participation from Novo Holdings and Blackrock to expand the proprietary drug pipeline.
"We believe Exscientia’s innovative use of AI to discover and design better quality drugs with greater efficiency has the potential to create important medicines faster than ever before. With the convergence of technology and biology, drug discovery is rapidly evolving in ways that will reshape the industry. The Exscientia team have been leaders in AI-based drug discovery since the field’s inception and we believe they will continue shaping its future."
The investment round was led by SoftBank Vision Fund 2 and Tencent Investment.
"Our global footprint, leadership, and strategic position in the innovation economy have enabled us to attract top investors, customers, and talent. Adding Softbank Vision Fund 2 and Tencent to our notable roster of investors will help solidify PatSnap as the industry standard for innovation intelligence. Both have deep investment expertise with AI-led companies and proven track records supporting sustainable company growth."
The investment from the SoftBank Vision Fund will accelerate global growth and technology development.
"We are agents of technological disruption with a mission to make available finance at the lowest possible cost for our clients and their suppliers, whilst opening up a whole new asset class to global investors."
